Mexico's Genomma Lab recorded strong double-digit growth for its OTC business in the second quarter as sales more than doubled at its US consumer health operation. 

A diclofenac topical analgesic is first, likely followed by a line extension for its Prevacid 24HR PPI brand. Perrigo also plans to introduce natural-based products that “leverage our expertise in Europe."

A court in Dublin has considered Perirrgo's challenge to Ireland tax authorities' ’ 2018 order to pay $1.9bn additional taxes from its 2013 acquisition of Elan that established it as an Irish firm. “We're just probably within 6 months now that we should get some kind of an answer in that regard,” says CEO Murray Kessler.

Recently approved by the UK's MHRA for use by healthcare professionals, Abingdon Health's AbC-19TM Rapid Test is now being trailed with the British public for home use. Abingdon is confident that an MHRA-endorsed COVID-19 home test could be available "in the coming months.”

Bayer says the growing interest in self-care triggered by the coronavirus outbreak is here to stay, with demand showing no sign of slowing for dietary supplements as consumers look to give their immune systems a boost. While Bayer benefited from this in the second quarter, sales across its other Consumer Health categories went into reverse as a result of lockdowns and social distancing measures. 

The pandemic's impact was mentioned only in FDA's calculations for fees including those established by PDUFA. In addition to prescription drug applications, PDUFA fees are charged for OTC switch applications and other proposals for ingredients that are not part of an OTC monograph to be made available nonprescription.

Legal experts say the EU already prohibits cosmetic use of CBD sourced from hemp flowers, and it now appears that food supplement use could be held to the same standard. The World Health Organization has recommended changes to the half-century-old international treaty governing narcotic controls, which could help to resolve the situation, but there are reports of UN pushback.

The latest draft amendments to the California’s Air Resources Board’s Consumer Products Regulations would provide manufacturers with some of the flexibility industry has been seeking, while still aiming to cut volatile organic compound levels across hair-care categories, as well as personal fragrance products.

Personal-care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Colgate won’t provide full-year 2020 guidance even as the company reports 5.5% organic growth in the second quarter. Its sales in North America grew 24% on pandemic-related purchasing and price increases.

Fabric & Home Care sales jumped 11% for the quarter, and Baby, Feminine & Family Care, 3%, reflecting consumer priorities during the COVID-19 pandemic. Beauty, impacted by travel retail’s nosedive, and Grooming, something consumers are doing considerably less of at home, were less impressive, but the units still grew in fiscal 2020 overall.

As expected, the National Medical Products Administration has issued four draft subsidiary regulations in rapid succession since publishing China’s new, finalized framework regulation for cosmetic products at the end of June. The documents include Technical Guidelines for Cosmetic Safety Assessment, a topic on which industry has been eagerly awaiting clarity.

Procter & Gamble, through its UK wellness subsidiary Nature's Best, is on-trend with new vegan vitamin D3 and iron supplements. Nature's Best has also launched three other vitamin D3 products in the country, as well as an ashwagandha supplement. 

Legal experts say the EU already prohibits cosmetic use of CBD sourced from hemp flowers, and it now appears that food supplement use could be held to the same standard. The World Health Organization has recommended changes to the half-century-old international treaty governing narcotic controls, which could help to resolve the situation, but there are reports of UN pushback.

Bayer says the growing interest in self-care triggered by the coronavirus outbreak is here to stay, with demand showing no sign of slowing for dietary supplements as consumers look to give their immune systems a boost. While Bayer benefited from this in the second quarter, sales across its other Consumer Health categories went into reverse as a result of lockdowns and social distancing measures. 

Nomolotus discontinued social media claims that its herbal supplement supports users’ immune systems during the COVID-19 pandemic and customers reviews referencing the virus after the National Advertising Division questioned the statements as misleading. 

Announcing rates for user fees authorized by Food Safety Modernization Act, FDA says supplement and food firms would be charged $263 an hour should agency officials need to re-inspect a US facility in FY 2021 and $310 an hour for facilities in other countries. Without a guidance for small businesses to request lower rates, the fees won't be imposed.

The pandemic's impact was mentioned only in FDA's calculations for fees including those established by PDUFA. In addition to prescription drug applications, PDUFA fees are charged for OTC switch applications and other proposals for ingredients that are not part of an OTC monograph to be made available nonprescription.

The Japanese government has approved a raft of measures aimed at expanding the country's consumer health market, including reforms to an Evaluation Committee that has not lived up to its promise of expediting Rx-to-OTC switches. 

Recent surveys from consulting, retail analytics and e-commerce logistics firms support the views of leading beauty and personal-care companies that are modifying their approaches in light of consumers’ changing means and preferences during COVID-19.

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.